Quote | Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH)
Last: | $1.17 |
---|---|
Change Percent: | 0.93% |
Open: | $1.06 |
Close: | $1.17 |
High: | $1.22 |
Low: | $1.06 |
Volume: | 370,083 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH)
2024-06-11 08:15:03 ET H.C. Wainwright analyst issues BUY recommendation for RVPH on June 11, 2024 06:40AM ET. The previous analyst recommendation was Buy. RVPH was trading at $1.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...
Message Board Posts | Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH)
Subject | By | Source | When |
---|---|---|---|
did everybody leave because it got too expensive | ernie44 | investorshub | 02/05/2023 4:40:06 PM |
you can expect a financing in the first | tootalljones | investorshub | 11/16/2022 11:30:31 PM |
No idea | Alan Brown | investorshub | 11/06/2022 3:54:34 AM |
What happened? | govprs | investorshub | 11/04/2022 8:57:45 PM |
Is this stock going to replicate the rally | Alan Brown | investorshub | 11/04/2022 9:50:58 AM |
News, Short Squeeze, Breakout and More Instantly...
Reviva Pharmaceuticals Holdings Inc. Company Name:
RVPH Stock Symbol:
NASDAQ Market:
Reviva Pharmaceuticals Holdings Inc. Website:
2024-06-11 08:15:03 ET H.C. Wainwright analyst issues BUY recommendation for RVPH on June 11, 2024 06:40AM ET. The previous analyst recommendation was Buy. RVPH was trading at $1.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...
CUPERTINO, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...